Actively Recruiting
Evaluating a Special Exclusion Diet Alongside Standard Treatment for Children and Teens With Juvenile Idiopathic Arthritis
Led by Meyer Children's Hospital IRCCS · Updated on 2025-03-13
20
Participants Needed
1
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the effects of an exclusion diet on patients aged 6 to 18 with juvenile idiopathic arthritis JIA, focusing on specific forms such as enthesitis-related arthritis and oligoarticular types. The study is exploratory and randomized, designed to evaluate the diets impact within a 4-week period based on evidence from a similar dietary approach used in Crohns disease. The goal is to assess improvements in disease activity and tolerability of this dietary intervention. Participants will be randomly assigned to one of two groups one receiving standard care with a free diet, and the other following the Crohn Disease Exclusion Diet CDED combined with partial enteral nutrition. The dietary intervention aims to induce remission in the first 4 weeks without changing existing drug therapies initially. If patients do not improve or worsen, they will receive rescue standard care treatment. The study is open-label and includes an add-on dietary approach. Throughout the study, participants will be monitored at baseline, 4 weeks, and 8 weeks for improvements in juvenile arthritis symptoms using the Juvenile Arthritis Disease Activity Score JADAS. Additional assessments include adherence to the diet, inflammation markers like Reactive C Protein and erythrocyte sedimentation rate, and safety monitoring. The study spans several weeks, with ongoing evaluation of responses to the diet and any necessary adjustments in treatment.
CONDITIONS
Brief Title
Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis
Research Team
P
Polo Lionetti, MD, PhD, Ordinary Professor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here